Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2016
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillationJan Beyer-Westendorf, Birgit Ehlken, Thomas Evers
Journal of Thrombosis and Thrombolysis|February 19, 2013
Pharmacokinetics of rivaroxaban after bariatric surgery: a case reportAdrian Mahlmann, Siegmund Gehrisch, Jan Beyer-Westendorf
Thrombosis and Haemostasis|July 13, 2013
Successful treatment of acute portal vein thrombosis with rivaroxabanSven Pannach, Jana Babatz, Jan Beyer-Westendorf
Thrombosis Research|December 9, 2008
Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shockJan Beyer, Kai Halbritter, Matthias Weise, et al.
Orthopedic Research and Reviews|February 19, 2019
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practiceJan Beyer-Westendorf, Patrick Mouret, Alexander Gg Turpie
Journal of Thrombosis and Thrombolysis|November 11, 2021
Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MSLea Brückner, Jan Beyer-Westendorf, Oliver Tiebel, et al.
Thrombosis Research|February 23, 2024
Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registryLuise Tittl, Sandra Marten, Christiane Naue, et al.
Thrombosis Research|May 4, 2010
Cancer in males and risk of venous thromboembolismJan Beyer-Westendorf, Sebastian Werth, Kai Halbritter, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 6, 2015
Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)Sebastian Werth, Tomás Breslin, Fionnuala NiAinle, et al.
Thrombosis Research|March 12, 2021
5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC RegistryLuise Tittl, Sandra Marten, Christiane Naue, et al.
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2016
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillationJan Beyer-Westendorf, Birgit Ehlken, Thomas Evers
Journal of Thrombosis and Thrombolysis|February 19, 2013
Pharmacokinetics of rivaroxaban after bariatric surgery: a case reportAdrian Mahlmann, Siegmund Gehrisch, Jan Beyer-Westendorf
Thrombosis and Haemostasis|July 13, 2013
Successful treatment of acute portal vein thrombosis with rivaroxabanSven Pannach, Jana Babatz, Jan Beyer-Westendorf
Thrombosis Research|December 9, 2008
Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shockJan Beyer, Kai Halbritter, Matthias Weise, et al.
Orthopedic Research and Reviews|February 19, 2019
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practiceJan Beyer-Westendorf, Patrick Mouret, Alexander Gg Turpie
Journal of Thrombosis and Thrombolysis|November 11, 2021
Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MSLea Brückner, Jan Beyer-Westendorf, Oliver Tiebel, et al.
Thrombosis Research|February 23, 2024
Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registryLuise Tittl, Sandra Marten, Christiane Naue, et al.
Thrombosis Research|May 4, 2010
Cancer in males and risk of venous thromboembolismJan Beyer-Westendorf, Sebastian Werth, Kai Halbritter, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 6, 2015
Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)Sebastian Werth, Tomás Breslin, Fionnuala NiAinle, et al.
Thrombosis Research|March 12, 2021
5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC RegistryLuise Tittl, Sandra Marten, Christiane Naue, et al.
Pageof 23